BioFocus DPI signs new compound management agreement  30-6-2008
BioFocus DPI will provide compound management and related services to Sepracor Inc., a leader in respiratory and central nervous system disorder medicines.  Total contract value for Galapagos, BioFocus DPI’s parent company, is €1 million ($1.5... » read more

California Stem Cell and BioFocus DPI to collaborate in ALS Association-funded research using human motor neurons  20-5-2008
Through a collaboration with California Stem Cell, BioFocus DPI is applying its target discovery engine to screen human motor neurons in a high-throughput, high-content screening assay for amyotrophic lateral sclerosis (ALS or “Lou Gehrig’s... » read more

19-5-2008 |

BioFocus DPI to perform medicinal chemistry services for UCL research project

6-5-2008 |

BioFocus DPI and Allergan enter drug discovery collaboration

8-4-2008 |

BioFocus DPI releases five new compound libraries

7-4-2008 |

BioFocus DPI launches ‘Intelligent Screening’ platform at SBS

19-3-2008 |

BioFocus DPI takes global license for Cresset’s molecular field software

18-3-2008 |

BioFocus DPI to distribute NIH’s Clinical Compound Collection

19-2-2008 |

BioFocus DPI launches ADME/PK service and software platform

14-1-2008 |

BioFocus DPI extends drug discovery collaboration with Lilly

3-1-2008 |

BioFocus DPI enters into oncology target discovery collaboration with Janssen Pharmaceutica